Related Experiment Video
Updated: Aug 16, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Tumor-specificity and apoptosis-inducing activity of stilbenes and flavonoids
Shahead Ali Chowdhury1, Kaori Kishino, Rie Satoh
1Meikai Pharmaco-Medical Laboratory (MPL), Meikai University School of Dentistry, Sakado, Saitama, Japan.
Abstract:
A total of eleven stilbenes [1-6] and flavonoids [7-11] were investigated for their tumor- specific cytotoxicity and apoptosis-inducing activity, using four human tumor cell lines (squamous cell carcinoma HSC-2, HSC-3, submandibular gland carcinoma HSG and promyelocytic leukemia HL-60) and three normal human oral cells (gingival fibroblast HGF, pulp cell HPC, periodontal ligament fibroblast HPLF). All of the compounds, especially sophorastilbene A [1], (+)-alpha-viniferin [2], piceatannol [5], quercetin [9] and isoliquiritigenin [10], showed higher cytotoxicity against the tumor cell lines than normal cells, yielding tumor-specific indices of 3.6, 4.7, >3.5, >3.3 and 4.0, respectively. Among the seven cell lines, HSC-2 and HL-60 cells were the most sensitive to the cytotoxic action of these compounds. Sophorastilbene A [1], piceatannol [5], quercetin [9] and isoliquiritigenin [10] induced internucleosomal DNA fragmentation and activation of caspases -3, -8 and -9 dose-dependently in HL-60 cells. (+)-alpha-Viniferin [2] showed similar activity, but only at higher concentrations. All the compounds failed to induce DNA fragmentation and activated caspases to much lesser extents in HSC-2 cells. Western blot analysis showed that sophorastilbene A [1], piceatannol [5] and quercetin [9] did not induce any consistent changes in the expression of pro-apoptotic proteins (Bax, Bad) and antiapoptotic protein (Bcl-2) in HL-60 and HSC-2 cells. An undetectable expression of Bcl-2 protein in control and drug-treated HSC-2 cells may explain the relatively higher sensitivity of this cell line to stilbenes and flavonoids.
Insights
Eleven stilbenes and flavonoids show promising tumor-specific cytotoxicity. Sophorastilbene A and quercetin exhibit significant anti-cancer activity, inducing apoptosis in cancer cells while sparing normal cells.
Area of Science:
- Natural Products Chemistry
- Pharmacology
- Cancer Biology
Background:
- Stilbenes and flavonoids are natural compounds with potential therapeutic applications.
- Investigating their anti-cancer properties is crucial for developing new treatments.
Purpose of the Study:
- To evaluate the tumor-specific cytotoxicity and apoptosis-inducing activity of eleven stilbenes and flavonoids.
- To compare the effects of these compounds on various human tumor and normal oral cell lines.
Main Methods:
- Cytotoxicity assays were performed on four human tumor cell lines (HSC-2, HSC-3, HSG, HL-60) and three normal human oral cell lines (HGF, HPC, HPLF).
- Apoptosis induction was assessed by measuring DNA fragmentation and caspase activation (caspases -3, -8, -9) in sensitive cell lines.
- Western blot analysis was used to examine the expression of key apoptosis-related proteins (Bax, Bad, Bcl-2).
Main Results:
- Several compounds, notably sophorastilbene A, (+)-alpha-viniferin, piceatannol, quercetin, and isoliquiritigenin, demonstrated higher cytotoxicity against tumor cells than normal cells.
- The HSC-2 and HL-60 cell lines were most sensitive to the cytotoxic effects.
- Sophorastilbene A, piceatannol, quercetin, and isoliquiritigenin induced DNA fragmentation and caspase activation in HL-60 cells, indicating apoptosis induction.
Conclusions:
- Selected stilbenes and flavonoids exhibit significant tumor-specific cytotoxicity and apoptosis-inducing potential.
- The compounds' efficacy varies depending on the cell line, with HSC-2 and HL-60 being particularly sensitive.
- Further research into these compounds could lead to novel anti-cancer therapeutics.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs that Stabilize Microtubules
Cancer Prevention
Some...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
The Intrinsic Apoptotic Pathway
